Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of the Aulea Veloxion™ Disposable Resectoscope System for Operational Efficiency in Surgical Management of Benign Prostatic Hyperplasia (BPH)
Sponsor: Chinese University of Hong Kong
Summary
Prospective, single-arm, single-site, post-market device study; all procedures use Veloxion™ per IFU.
Official title: Prospective, Single-Site, Single-Arm Evaluation of the Aulea Veloxion™ Disposable Resectoscope System for Operational Efficiency in Surgical Management of Benign Prostatic Hyperplasia (BPH)
Key Details
Gender
MALE
Age Range
30 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-07-16
Completion Date
2027-12-31
Last Updated
2026-07-27
Healthy Volunteers
No
Conditions
Interventions
TURP using the Aulea Veloxion™ Disposable Resectoscope System
TURP will be performed by Aulea Veloxion™ Disposable Resectoscope System. The resectoscopes are single-use and ensure consistent quality and no cross-contamination. The automated fluid management system continuously monitors and manages intravesical pressure while actively evacuating tissue to prevent clogging. The active power generation system optimize plasma generation for effective resection and extended equipment life. This system allows transurethral resection of prostate to be performed in a motorized and highly effective manner. This study is designed to prospectively characterize operational efficiency in real-world BPH resections using the cleared device platform.
Aulea Veloxion™ Disposable Resectoscope System
Veloxion™ platform disposable resectoscope is FDA-cleared for treatment of BPH. It is an all-in-one, platform that combines fluid control, video pipeline and energy generator. The resectoscopes are single-use and ensure consistent quality and no cross-contamination. The automated fluid management system continuously monitors and manages intravesical pressure while actively evacuating tissue to prevent clogging. The active power generation system optimize plasma generation for effective resection and extended equipment life. This system allows transurethral resection of prostate to be performed in a motorized and highly effective manner. This study is designed to prospectively characterize operational efficiency in real-world BPH resections using the cleared device platform.
Locations (1)
Prince of Wales Hospital
Shatin, Hong Kong